Quercetin
Best-in-class: Quercetin Phytosome
A flavonoid antioxidant with anti-inflammatory, antihistamine and (theorized) senolytic interest, in an absorption-enhanced phytosome.
Quercetin quick facts
| Suggested dose | 250–500 mg of a bioavailable form daily. |
| How often | Daily |
| Who it's for | Allergy/histamine support, cardiovascular and anti-inflammatory goals, longevity experimenters. |
Weak as a standalone senolytic — its role in the D+Q protocol is as the junior partner. The zinc ionophore property is the most practically interesting and least discussed. It is also a CYP3A4 and P-glycoprotein inhibitor, which raises levels of a range of medications and is a real interaction rather than a footnote. The plain powder is poorly absorbed enough that dose comparisons across products are close to meaningless.
How Quercetin actually works
A flavonoid with several distinct actions: mast-cell stabilization through inhibition of degranulation, senolytic activity in combination with dasatinib, zinc ionophore activity that carries zinc across cell membranes, and inhibition of several inflammatory kinases. Bioavailability is famously poor, which the phytosome formulation addresses by complexing it with phospholipid.
Where to get Quercetin
Buy Quercetin Phytosome at Thorne →The evidence for Quercetin
Graded by what exists behind each claim.
✅ Clinically validated
- RCTs show modest blood-pressure reduction, strongest in hypertensive individuals.
- Some evidence for reduced exercise-induced inflammation and URTI incidence in athletes.
📊 Correlative data
- Higher dietary flavonoid intake is associated with lower cardiovascular and inflammatory disease in cohorts.
🧪 Theoretical / extrapolated benefits
- Popular as a 'senolytic' (with fisetin) to clear senescent cells — exciting preclinical/animal work, human longevity outcomes unproven.
How to read these tiers: they say how much human evidence exists, not how well something works — and ✗ flags harm, never a disappointing trial. How the evidence tiers work →
What Quercetin actually does
Quercetin is 3,3',4',5,7-pentahydroxyflavone. Count the hydroxyls, because that number is the whole story: five free phenolic groups, and a free phenolic group is exactly what a UDP-glucuronosyltransferase or a sulfotransferase is built to grab. The molecule that does interesting things in a dish and the molecule that circulates in your blood after you swallow a capsule are not the same chemical species, and almost every claim made for this flavonol quietly assumes they are.
What it does at the protein, when it can get there. Three actions are named on the label and each has a real target. Mast-cell stabilization: quercetin suppresses IgE-triggered degranulation, measured as beta-hexosaminidase and histamine release, in rat basophilic leukemia and human mast-cell lines. Kinase inhibition: it is an ATP-competitive inhibitor at the PI3K catalytic site, which is why it turns up in almost every kinase counter-screen ever run — quercetin is a promiscuous binder at the adenine pocket, not a selective drug. And senolysis: the screen that produced the dasatinib-plus-quercetin pairing identified quercetin as the partner that covers the BCL-2 family and PI3K-dependent survival programs senescent cells use to resist apoptosis Zhu 2015. The pairing itself, its intermittent dosing logic and its two human pilots belong to this site's dasatinib-quercetin page and are argued there; what that page does not ask, and this one does, is what concentration any of it needs.
The enzymes that decide the answer are in your gut wall, not in the target tissue. Quercetin glycosides are hydrolyzed at the brush border by lactase-phlorizin hydrolase, or taken up as glucosides via SGLT1 and deglycosylated inside the enterocyte by cytosolic beta-glucosidase. The aglycone released there is immediately conjugated — glucuronidated by intestinal UGT1A and sulfated by SULT1A — and a large share is pumped straight back into the lumen by efflux transporters before it ever reaches portal blood. What survives is conjugated again in the liver. The species that actually circulate are quercetin-3-O-glucuronide, quercetin sulfates and the 3'-methylated metabolite isorhamnetin and its conjugates. Manach's review of 97 human bioavailability studies puts peak plasma concentrations for polyphenols below 1 micromolar after a dietary dose and reaching only a few micromolar for the best-absorbed classes, almost entirely as conjugate rather than parent Manach 2005.
So do the subtraction. Mast-cell and senolytic work is run at tens of micromolar of free aglycone. Circulating free aglycone after an oral dose is a minority species in a total pool that is itself sub-micromolar to low-micromolar Manach 2005. That is one to two orders of magnitude on concentration and a change of chemical identity, because a glucuronide has a bulky sugar sitting on the hydroxyl the target was binding. There is a real counter-argument — tissue beta-glucuronidase, which is abundant in inflamed tissue and inside neutrophils, can strip the glucuronide back off locally, so the conjugate may act as a circulating pro-drug delivered preferentially to inflamed sites. That is the most interesting hypothesis in this literature and it is labeled extrapolation: nobody has measured free quercetin aglycone in human inflamed tissue after an oral dose.
Cell, rodent, human — and where it stops
In cells. Human and rodent cell lines, 10–100 micromolar unconjugated quercetin, 24–72 hours, reading degranulation, kinase phosphorylation and apoptosis of senescent cells Zhu 2015. Hold that range.
In rodents. Mice, oral or intraperitoneal, typically 20–50 mg/kg, days to weeks. Body-surface scaling puts 50 mg/kg in a mouse at roughly 4 mg/kg in a person — about 280 mg for a 70 kg adult, which is inside the label range, so the rodent dose is not the obstacle here. The obstacle is that mice were dosed with aglycone and measured within hours.
In people, and the human evidence is real but small. Seven randomized trials, nine treatment arms, 587 patients, doses at or above 500 mg/day: systolic blood pressure fell by a weighted mean of 3.04 mmHg (95% CI −5.75 to −0.33, P = 0.028) and diastolic by 2.63 mmHg (95% CI −3.26 to −2.01, P < 0.001) Serban 2016. That is a genuine signal and it is also a small one — three millimetres of mercury is about a third of what a starting dose of a thiazide does, and the confidence interval on the systolic estimate nearly touches zero.
The specific obstacle is that the trials were run at 500 mg and above, and the form question sits underneath the dose question. A meta-analysis of 31 human intervention studies ranked the forms directly: quercetin-3-O-oligoglucosides gave twice the bioavailability of quercetin-3-O-glucoside, ten times that of quercetin-3-O-rutinoside — rutin, the cheapest and commonest supplement source — and about twenty times that of quercetin aglycone Liu 2025. A twenty-fold spread between forms sold under the same word on the front of the bottle is larger than any effect size in the blood-pressure meta-analysis. Two people taking ‘500 mg of quercetin’ can be running experiments that differ by more than an order of magnitude in exposure, and neither label tells them which one they are in.
And the senolytic claim does not survive this transfer at all. Senescent-cell killing needs a concentration held long enough to push a cell past its apoptotic threshold. Quercetin taken alone, at 500 mg of an ordinary form, is one to two orders of magnitude short of the dish Manach 2005Zhu 2015. That is not an argument that senolysis is fake; it is an argument that the bottle on your shelf is not a senolytic, and the word longevity on its label is borrowed from an experiment it cannot reproduce.
Quercetin — which form, and does it matter
This is the one supplement where the form section is more important than the dose section, and the numbers say so. Aglycone, rutin, isoquercitrin and the enzymatically modified oligoglucosides differ by up to twentyfold in human bioavailability Liu 2025. Rutin — quercetin-3-O-rutinoside — is the worst of the commonly sold sources and needs colonic bacteria to cleave its rhamnose before anything is absorbed at all, which means the answer depends on a microbiome you have not measured.
The phytosome is a real formulation with a real pharmacokinetic study, and the study is single-dose. Twelve healthy volunteers, film-coated tablets, plasma sampled at twelve time points from 0 to 24 hours, and exposure reported as up to twenty times that usually seen after a dose of quercetin Riva 2019. A phospholipid complex works by carrying the flavonol into the enterocyte inside a lipid envelope, which changes both the absorption route and the amount presented to gut-wall conjugation at once. Twenty-fold is a big number and it is worth paying for. It is also a number from twelve people on one day, with no clinical endpoint attached.
What the filed label actually declares, and the arithmetic it hides. The Thorne phytosome product this site links to declares 250 mg of quercetin phytosome per capsule, taken one capsule two to three times daily with meals Office of Dietary Supplements. The declared mass is the phospholipid complex, not the quercetin inside it, and the panel does not state the flavonol content — so a reader cannot map 250 mg of complex onto the 500 mg of quercetin used in the blood-pressure trials Serban 2016. This site's card gives ‘250–500 mg of a bioavailable form daily’, which at one to two capsules is below the label's own suggested three. If you are taking this for blood pressure, the trials are at the top of that range and above.
Take it with food, and the reason is mechanical rather than traditional. A phospholipid complex is absorbed with dietary lipid; the manufacturer's own suggested use says with meals Office of Dietary Supplements. An aglycone powder taken fasted is the worst of both worlds — the least bioavailable form, without the fat that would help it.
What would have to be true, and how you would know it was not
1. Systolic blood pressure down 3–5 mmHg at 8 weeks on 500 mg/day or more, and only if you start hypertensive. The pooled estimate is 3.04 mmHg systolic and 2.63 mmHg diastolic, and the sub-analyses in that literature put the effect where baseline pressure is high Serban 2016. Measure it the way the trials did: home cuff, seated, same time each morning, seven consecutive days averaged, before and after. A single reading cannot resolve a 3 mmHg effect and neither can a clinic visit.
2. hs-CRP down 0.3–1.0 mg/L at 12 weeks, and only from a baseline above 2 mg/L. This is the marker the anti-inflammatory claim implies and it is the one the reader can buy. Someone already below 1 mg/L has no room to move and should not read a flat result as failure.
3. Uric acid down, and this is the prediction most likely to surprise you. Quercetin is a xanthine oxidase inhibitor in vitro — the same enzyme allopurinol blocks — and unlike the senolytic story this one does not need the compound to reach a distant tissue at high concentration, because urate production runs through liver and gut. Predict a fall of 0.2–0.5 mg/dL at 4 weeks in someone starting above 6 mg/dL. Labeled extrapolation: this has not been tested in the trials cited on this page, and a null result would be informative rather than embarrassing.
4. The prediction that cuts against the product: nothing measurable will happen to any marker of aging. No senescence marker, no epigenetic clock, no p16 transcript in a blood sample will move on quercetin alone at a label dose, because the exposure is one to two orders of magnitude below the concentration at which senolysis was demonstrated Zhu 2015Manach 2005. If you are buying this bottle for longevity rather than for allergy or blood pressure, the honest expectation is a null, and this page would rather say so before you spend the money than after.
What will fool you: the season. Quercetin's most convincing subjective effect is antihistamine-like, and pollen counts fall on their own. Anyone who starts at the peak of their season will credit the capsule with the calendar.
What nobody has tested yet
Nobody has run a head-to-head bioavailability trial with a clinical endpoint attached. The forms differ twentyfold in exposure Liu 2025 and the phytosome study reports up to twentyfold again over unformulated quercetin Riva 2019, but no trial has randomized people to phytosome versus aglycone versus rutin at matched flavonol content and read blood pressure. Until somebody does, the blood-pressure meta-analysis Serban 2016 is pooling arms whose real exposures may differ by more than the effect being measured.
Free aglycone has never been measured in human tissue after an oral dose. The beta-glucuronidase pro-drug hypothesis at the top of this page predicts that inflamed tissue deconjugates circulating quercetin glucuronide locally and generates aglycone concentrations far above plasma. A skin-blister or synovial-fluid sample, taken alongside plasma, with the aglycone and the glucuronide quantified separately, would settle in one afternoon whether the whole concentration objection on this page is the right objection.
Nobody has measured a senescence marker in a person taking quercetin alone. Every human senolysis measurement to date has been of the combination Zhu 2015. A single-agent arm, at the highest tolerated quercetin exposure, with adipose p16INK4a as the read-out, would either rescue the solo senolytic claim or retire it. The fact that this arm has never been run, twenty years into the quercetin literature, is itself informative.
And nobody has run it past twelve weeks at a gram. The safety review states plainly that adequate data are lacking for long-term use beyond twelve weeks at doses at or above 1000 mg Andres 2018. A twelve-month trial at 1000 mg/day with renal function, thyroid function and a full lipid panel would answer the three open safety questions at once.
Quercetin — its own safety story, not its category's
The CYP3A4 and P-glycoprotein problem is this compound's real risk, and it is a dose problem rather than a rare-reaction problem. Quercetin inhibits CYP3A4 and P-glycoprotein, which together handle a very large share of orally administered drugs. The consequence is not an allergy; it is that a stable prescription dose becomes a higher blood level without anything about the prescription changing. Cyclosporin, tacrolimus and sirolimus are the sharp end — this site has a sirolimus level page for exactly this reason — and simvastatin and atorvastatin are the common end, where a raised level shows up as muscle ache rather than as a number. If you take a narrow-therapeutic-index drug, this is a conversation with whoever prescribes it, not a footnote.
The quinone chemistry, stated as chemistry rather than as alarm. A catechol B-ring is oxidizable, and oxidation of quercetin yields a reactive ortho-quinone that adds to protein and glutathione thiols. This is standard flavonol redox behavior and it is the mechanistic reason an antioxidant can behave as a pro-oxidant at high concentration. Labeled extrapolation, clearly: nobody has measured whole-blood glutathione in a person taking a gram of quercetin a day, and the safety review's position is that adverse effects have rarely been reported but that data above 1000 mg and beyond twelve weeks are inadequate Andres 2018. The practical reading is that the gram-a-day-forever protocol is the unstudied one, not the 500 mg seasonal one.
Kidney, and the route matters more than the dose. The reported nephrotoxicity signal sits with very high and intravenous exposure, which is a different pharmacokinetic situation from a capsule — intravenous dosing bypasses the gut-wall conjugation that removes most of an oral dose. Anyone with reduced eGFR who wants to take this long term should have creatinine and cystatin C measured before and at three months, because that is cheap and the alternative is guessing.
Bleeding and the blend trap. Quercetin has mild antiplatelet activity, which is additive with warfarin, apixaban, rivaroxaban, clopidogrel and aspirin, and pharmacodynamic rather than metabolic — it does not change a drug level, it changes a bruise. Two weeks off before surgery. And check what else you are taking: quercetin phytosome is also an ingredient in Thorne's PolyResveratrol-SR Office of Dietary Supplements, so a reader who follows this site's resveratrol page and its quercetin page at the same time is taking quercetin phytosome twice without either bottle mentioning the other.
Gastrointestinal upset and headache are the ordinary complaints, and tingling in the extremities appears at very high doses. Pregnancy and breastfeeding are unstudied rather than shown to be unsafe, which is not the same sentence and should not be read as the same reassurance.
Sources read for this page
- Serban MC, et al. Effects of Quercetin on Blood Pressure: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.. Journal of the American Heart Association 2016 · PMID 27405810
- Riva A, et al. Improved Oral Absorption of Quercetin from Quercetin Phytosome, a New Delivery System Based on Food Grade Lecithin. European Journal of Drug Metabolism and Pharmacokinetics 2019 · PMID 30328058
- Liu L, et al. Improving quercetin bioavailability: A systematic review and meta-analysis of human intervention studies. Food Chemistry 2025 · PMID 40037045
- Zhu Y, et al. The Achilles' heel of senescent cells: from transcriptome to senolytic drugs.. Aging Cell 2015 · PMID 25754370
- Andres S, et al. Safety Aspects of the Use of Quercetin as a Dietary Supplement.. Molecular Nutrition & Food Research 2018 · PMID 29127724
- Manach C, et al. Bioavailability and bioefficacy of polyphenols in humans. I. Review of 97 bioavailability studies.. American Journal of Clinical Nutrition 2005 · PMID 15640486
- Office of Dietary Supplements, National Institutes of Health. Quercetin Phytosome (Thorne) -- filed Supplement Facts panel: 250 mg quercetin phytosome per capsule, one capsule two to three times daily with meals. NIH Dietary Supplement Label Database, DSLD ID 336310
How you would know if it worked
There is no blood test for this one. That is not a criticism — it is a fact about the effect, and it changes how you should judge it.
- What to watch: Allergy symptoms, counted the way allergy trials count them: sneezing bouts and hours of blocked nose per day, plus the number of antihistamine tablets you took that week. Rescue-medication count is the endpoint that resists wishful thinking, because it is a purchase rather than an impression.
- How long before it means anything: Two to four weeks inside a season you can compare — ideally against the same weeks last year, since your own pollen calendar repeats. The antihistamine-like action is not cumulative, so if nothing has shifted by four weeks it is not going to.
- What will fool you: The pollen count, which does most of the work and gets none of the advertising. Symptoms fall when the count falls, so a run started at the peak ends looking impressive. The senolytic story is the other trap: it is why the word longevity is on the label, it comes from cell and animal work, and no human outcome supports it. You are buying an antihistamine-adjacent flavonoid with a longevity story attached.
Run it one variable at a time. Starting three things in one week means a result you cannot attribute, which is the same as no result.
Quercetin — safety & side effects
- GI upset and headache. Tingling in the extremities at very high doses.
- Inhibits CYP3A4 and P-glycoprotein — it raises levels of ciclosporin, some statins, and others. It also inhibits the transporters that clear quinolone antibiotics.
- Kidney damage has been reported at very high doses, particularly intravenous. Avoid above 1 g/day long-term without a reason.
- Mild antiplatelet activity. May affect thyroid hormone. Not established as safe in pregnancy or breastfeeding — not because harm is documented, but because these are the two populations systematically excluded from the trials. Absence of data is not reassurance.
Not medical advice. If you take prescription medication or have a diagnosed condition, check this against it with a pharmacist or doctor — pharmacists are underused and free.
- When to take it, and what to take it with
- Which form actually absorbs
- Who it's worth it for
- Best-in-class brand pick
- Coach Cam's stacks and notes
- Fasted or with food, and when in the day
- Morning or night, and why that window
- Around training, or deliberately away from it
- What it must not share a window with
Everything above is free and stays free. Skool is where it becomes a plan — Quercetin in an order, with the rest of what you're running.
Unlock in Skool — $10/mo →Bloodwork to run alongside Quercetin
Baseline first, then again at 8–12 weeks.
| Marker | What it’s watching for |
|---|---|
| hs-CRP (High-Sensitivity C-Reactive Protein) | The inflammation these are aimed at |
| ApoB (Apolipoprotein B) | Cardiovascular risk, measured properly |
| HbA1c (Hemoglobin A1c) | Glycation over three months |
| Comprehensive Metabolic Panel (CMP) | Liver and kidney baseline |
The Longevity Baseline panel covers these in one order — 13 markers, $219.10 with the discount applied.
Check results you already have → · All 103 markers A–Z
Quercetin — frequently asked questions
What is Quercetin?
A flavonoid antioxidant with anti-inflammatory, antihistamine and (theorized) senolytic interest, in an absorption-enhanced phytosome.
What is the suggested dose of Quercetin?
250–500 mg of a bioavailable form daily. This is a general reference for education only — statements have not been evaluated by the FDA and this is not medical advice.
Where can I find Quercetin dosing and the full breakdown?
The suggested dose and the full evidence — clinical, correlative and theoretical — are on this page. What's inside Skool is when to take it, which form actually absorbs, the brand worth buying and Coach Cam's stacks.
Where can I buy Quercetin?
Coach Cam sources Quercetin from Thorne, with 10% off auto-applied at checkout — use the buy link on this page.
Quercetin inside a finished plan
One arm of 1 Protocol Blueprint, free to read in full.
What Quercetin is used for
Quercetin appears under 1 goal in the goal router.
Related Longevity & Antioxidants supplements
Where this goes next
Quercetin is the senolytic arm of this plan. The page above is the free breakdown of one compound; the plan it belongs to — the dosing, the order to correct things in, the week-by-week schedule and what to retest — is a lesson inside Skool.